About US
Contact us
>>Back
China’s Leading DDS & formulation Event is Coming Back With Brand-new Highlights!
- Publisher：
- Publication：2012/10/22
Following the huge success of NDDS China 2011, CPhI will host 2nd NDDS China 2012 on 22-24, October in Shanghai, China.
Novel drug delivery is one of the fastest growing pharmaceutical sectors. The three most promising drug delivery systems in China are sustained/controlled release oral DDS, injection DDS and nanopartical DDS. At present there are over 1400 sustained/controlled release drugs worldwide. Sustained/controlled oral release formulation is one of the hotspots with annual increase in new product application and registration. Novel injection formulation research has also been paid much attention to. Peptide and protein depot drug delivery system, Prefilled syringes injection as well as freeze-dried injection are main products from Chinese enterprises. There are promising clinical and commercialization prospects of nanotechnology since it would improve the bioavailability of drugs when applied to oral drug delivery system and injection delivery system.
China’s drug delivery system and formulation research level lags behind but with great potential. China National 12th Five-Year Plan for Key New Drug R&D Projects has set Novel Drug Delivery System as a key development trend. How to realize product differentiation and enhance the research and commercialization level by making use of the latest drug delivery system and formulation strategy has become an urgent problem for pharmaceutical companies to solve.
Novel drug delivery is one of the fastest growing pharmaceutical sectors. The three most promising drug delivery systems in China are sustained/controlled release oral DDS, injection DDS and nanopartical DDS. At present there are over 1400 sustained/controlled release drugs worldwide. Sustained/controlled oral release formulation is one of the hotspots with annual increase in new product application and registration. Novel injection formulation research has also been paid much attention to. Peptide and protein depot drug delivery system, Prefilled syringes injection as well as freeze-dried injection are main products from Chinese enterprises. There are promising clinical and commercialization prospects of nanotechnology since it would improve the bioavailability of drugs when applied to oral drug delivery system and injection delivery system.
China’s drug delivery system and formulation research level lags behind but with great potential. China National 12th Five-Year Plan for Key New Drug R&D Projects has set Novel Drug Delivery System as a key development trend. How to realize product differentiation and enhance the research and commercialization level by making use of the latest drug delivery system and formulation strategy has become an urgent problem for pharmaceutical companies to solve.